Rejuvenation and biostimulation
What do we know about polynucleotides and PDRN for skin?
Polynucleotides and PDRN are being studied in aesthetic medicine. Understand the evidence limits and why stronger studies are still needed.
Related names, different products
Polynucleotides and PDRN frequently appear in discussions of skin quality and repair. Studied formulations are not necessarily equivalent. Before considering treatment, identify the exact product, its indication and the concern it is intended to address.
Promising but limited evidence
A systematic review of polynucleotides included small studies of low or moderate quality and found interesting skin outcomes. Its authors called for more rigorous research. Promising means worth studying, not a guaranteed benefit for each patient.
Do not extrapolate between indications
Another trial review examined rejuvenation, scars and wound healing. It identified differences in preparations, methods and measurements. An outcome in a wound does not automatically establish the same usefulness in healthy skin or define an appropriate aesthetic protocol.
A decision in context
Ask which evidence actually relates to your goal and what uncertainties remain. Discuss your history and previous treatments and request follow-up information. A novel ingredient does not replace individual assessment or justify promises of complete regeneration or permanent results.
A question that organizes information
Ask whether the explanation concerns the offered product or another studied formulation. Distinguishing these situations helps clarify which parts have direct evidence and which remain uncertain.